Liancheng Xu

Beijing Institute of Technology

Papers

1

Total Citations

57

H-Index

1

About

Dr. Liancheng Xu is a leading figure in the intersection of biomedical optics and oncology, with a primary focus on advancing laser ablation (LA) for tumor treatment. His seminal 2023 review, "The State-of-the-Art and Perspectives of Laser Ablation for Tumor Treatment," has already garnered 57 citations, establishing him as a key synthesizer of this rapidly evolving field. Dr. Xu’s major contribution lies in systematically mapping how converging technologies—optical, information, and robotic—are transforming LA from a niche procedure into a precise, minimally invasive therapeutic modality. By critically analyzing current clinical outcomes and technical bottlenecks, his work provides a roadmap for integrating real-time imaging and robotic guidance to enhance tumor targeting while sparing healthy tissue. This research directly addresses the profound impact tumors have on patient quality of life, offering a less traumatic alternative to conventional surgery. Dr. Xu’s perspective is particularly notable for bridging engineering innovation with clinical practicality, making his insights invaluable for researchers developing next-generation photonic tools and for clinicians seeking to expand LA’s role in personalized cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
57
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
The State-of-the-Art and Perspectives of Laser Ablation for Tumor Treatment
57 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Beijing Institute of Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago